Edition:
India

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

7.83EUR
20 Nov 2018
Change (% chg)

€-0.02 (-0.25%)
Prev Close
€7.85
Open
€7.80
Day's High
€7.91
Day's Low
€7.52
Volume
328,606
Avg. Vol
299,514
52-wk High
€9.44
52-wk Low
€4.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 16.88 -0.281
FY 2017 Dec '17 17.08 -0.457
Jun '17 15.55 -0.433
FY 2016 Dec '16 39.50 0.293
Jun '16 16.66 -0.059
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 11.00 11.00 11.00 --
Year Ending Dec-18 5 54.41 74.80 34.70 68.05
Year Ending Dec-19 4 150.65 164.20 124.10 74.12
Earnings (per share)
Quarter Ending Dec-18 1 -0.60 -0.60 -0.60 --
Year Ending Dec-18 5 -0.52 -0.12 -0.88 0.12
Year Ending Dec-19 3 0.42 0.99 0.09 0.41
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 213.63 65.14 49.76
EPS (TTM) % 286.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innate Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.23 -9.58 94 --
13 Week -2.14 -6.06 99 --
26 Week -6.57 -10.49 99 --
52 Week -8.20 -23.27 99 --
YTD -27.99 -34.68 91 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.01%
# of Holders: 54
Total Shares Held: 11,506,505
3 Mo. Net Change: -568,503
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 7
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.